Skip to main content
Clinical Trials/ACTRN12618002026202
ACTRN12618002026202
Completed
N/A

The role of vibration therapy in improving the health and mobility of young children with cerebral palsy.

Prof Paul Hofman0 sites34 target enrollmentDecember 18, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cerebral palsy
Sponsor
Prof Paul Hofman
Enrollment
34
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 18, 2018
End Date
October 23, 2021
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Prof Paul Hofman

Eligibility Criteria

Inclusion Criteria

  • Have diagnosed cerebral palsy with GMFCS I \- III
  • \- Be able to safely stand on the vibration platform
  • \- Be able to understand the researcher’s instructions and follow them

Exclusion Criteria

  • \- A bone fracture within 12 weeks of enrolment
  • \- Acute thrombosis, tendinitis, nephrolithiasis, discopathy or arthritis
  • \- History of clinically significant organic disease or findings on physical examination, which in the opinion of the Investigator would prevent the patient from completing the study.
  • \- History of using any of the following medications, regardless of dose, for at least 1 month, within 3 months of enrolment: anabolic agents, glucocorticoids (does not include inhaled glucocorticoids) or growth hormone.
  • \- History of botulinum toxin injection into lower limbs within 3 months of enrollment

Outcomes

Primary Outcomes

Not specified

Similar Trials